Holds one active US DMF and one valid CEP for levodopa, filing since 2024.
Holds 2 active US DMFs for levodopa, filing since 2009. Its GMP is recognised in 5 markets.
Holds one active US DMF for levodopa, filing since 2014.
Holds one valid CEP for levodopa, filing since 2025. Its 2016 FDA inspection closed as VAI, and its GMP is recognised in 4 markets.
Holds one active US DMF and one valid CEP for levodopa, filing since 2017. Its 2025 FDA inspection closed as OAI, and its GMP is recognised in 1 market.
Holds one active US DMF for levodopa, filing since 2025.
The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.
This page filters the worldwide Levodopa manufacturer list to companies based in China. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.
Start for free